Your browser doesn't support javascript.
loading
Keratoconus and the Impact of Treatment on Patients' Quality of Life: A Qualitative Study.
Fournié, Pierre; Acquadro, Michaël; Touboul, David; Cochener, Béatrice; Chiambaretta, Frédéric; Muraine, Marc; Borderie, Vincent; Bourges, Jean-Louis; Benmedjahed, Khadra; Tugaut, Béatrice; Bernheim, Diane; Bourcier, Tristan; Burillon, Carole; David, Thierry; Delbosc, Bernard; Gain, Philippe; Hoffart, Louis; Labetoulle, Marc; Laroche, Laurent; Malet, Florence; Orignac, Isabelle; Robert, Pierre-Yves; Thuret, Gilles; Vabres, Bertrand; Malecaze, François; Arnould, Benoit.
Afiliação
  • Fournié P; CHU Toulouse, Université Paul Sabatier, Toulouse, France.
  • Acquadro M; ICON Plc, Lyon, France.
  • Touboul D; CHU Bordeaux, Université de Bordeaux, Bordeaux, France.
  • Cochener B; CHU Brest, Université de Bretagne Occidentale, Brest, France.
  • Chiambaretta F; CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Muraine M; CHU Rouen, Université de Rouen, Rouen, France.
  • Borderie V; CHNO des 15-20, GRC 32, Sorbonne Université, Paris, France.
  • Bourges JL; Université de Paris, APHP, Hôpital Cochin, Paris, France.
  • Benmedjahed K; ICON Plc, Lyon, France. Khadra.benmedjahed@iconplc.com.
  • Tugaut B; ICON Plc, Lyon, France.
  • Bernheim D; CHU Grenoble, Université Grenoble-Alpes, Grenoble, France.
  • Bourcier T; Hôpitaux Universitaires de Strasbourg (NHC), Université de Strasbourg, Strasbourg, France.
  • Burillon C; CHU Lyon, Université Lyon 1, Lyon, France.
  • David T; CHU Marseille, Université Aix-Marseille, Marseille, France.
  • Delbosc B; CHU Besançon, Université de Franche Comté, Besançon, France.
  • Gain P; CHU Saint-Etienne, Université Jean Monnet, Saint-Etienne, France.
  • Hoffart L; Clinique Monticelli-Vélodrome, Marseille, France.
  • Labetoulle M; CHU Bicêtre, APHP, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Laroche L; Faculté de Médecine Sorbonne Université, Institut de La Vision-Paris, Paris, France.
  • Malet F; , Bordeaux, France.
  • Orignac I; CHU Nantes, Nantes, France.
  • Robert PY; CHU Limoges, Université de Limoges, Limoges, France.
  • Thuret G; CHU Saint-Etienne, Université Jean Monnet, Saint-Etienne, France.
  • Vabres B; CHU Nantes, Nantes, France.
  • Malecaze F; CHU Toulouse, Université Paul Sabatier, Toulouse, France.
  • Arnould B; ICON Plc, Lyon, France.
Ophthalmol Ther ; 12(4): 1939-1956, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37157013
ABSTRACT

INTRODUCTION:

Keratoconus has a significant impact on patients' quality of life (QoL), from diagnosis to the advanced stages of the disease. The aim of this research was to identify domains of QoL affected by this disease and its treatment.

METHODS:

Phone interviews were conducted using a semi-structured interview guide, with patients with keratoconus stratified according to their current treatment. A board of keratoconus experts helped identify the guide's main themes.

RESULTS:

Thirty-five patients (rigid contact lenses, n = 9; cross-linking, n = 9; corneal ring implants, n = 8; and corneal transplantation, n = 9) were interviewed by qualitative researchers. Phone interviews revealed several QoL domains affected by the disease and its treatments "psychological", "social life", "professional life", "financial costs" and "student life". All domains were impacted, independently of the treatment history. Few differences were found between treatment regimens and keratoconus stages. Qualitative analysis enabled the development of a conceptual framework based on Wilson and Cleary's model for patient outcomes common to all patients. This conceptual model describes the relationship between patients' characteristics, their symptoms, their environment, their functional visual impairment and the impact on their QoL.

CONCLUSIONS:

These qualitative findings supported the generation of a questionnaire to evaluate the impact of keratoconus and its treatment on patients' QoL. Cognitive debriefings confirmed its content validity. The questionnaire is applicable for all stages of keratoconus and treatments and may help tracking change over time in regular clinical settings. Psychometric validation is yet to be performed before its use in research and clinical practices.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Ophthalmol Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França